In addition, JSH-23 abrogated the effect of LEU on the activation of NLRP3, indicating that mTOR activates NLRP3 via NF-κB. Rg1 also significantly decreased NLRP3 levels in the hyperlipidemia-exposed podocytes. This evidence concerns the gene NFKB1 and hyperlipidemia.